This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Angelica Therapeutics, Inc.. Active years: 2012-2018.
Company Filing History:
Years Active: 2012-2018
Title: Alyson Jane Rust: Innovator in Modified Toxins
Introduction
Alyson Jane Rust is a prominent inventor based in Suffolk, GB. She has made significant contributions to the field of biotechnology, particularly in the development of modified toxins. With a total of 3 patents to her name, her work focuses on enhancing the efficacy and safety of therapeutic agents.
Latest Patents
Alyson's latest patents include innovative compositions of modified toxins that exhibit cytotoxicity and reduced immunogenicity. One of her notable inventions involves polypeptide toxophores derived from a modified diphtheria toxin, where specific modifications are made to amino acid residues of T-cell epitopes. This advancement aims to improve the treatment of both malignant and non-malignant diseases. Another patent addresses the reduction of binding to vascular endothelium, thereby minimizing the risk of Vascular Leak Syndrome. These modifications enhance the therapeutic potential of diphtheria toxins, making them more effective in clinical applications.
Career Highlights
Alyson is currently associated with Angelica Therapeutics, Inc., where she continues to push the boundaries of medical research. Her work has garnered attention for its innovative approach to toxin modification, which holds promise for various therapeutic applications.
Collaborations
Alyson collaborates with talented individuals in her field, including Deepshikha Datta and Simon Keen. These partnerships enhance the research and development process, fostering a collaborative environment that drives innovation.
Conclusion
Alyson Jane Rust is a trailblazer in the field of modified toxins, with a focus on improving therapeutic outcomes. Her contributions are paving the way for advancements in medical treatments, showcasing the importance of innovation in biotechnology.